About
Uromedica, Inc. is a Minnesota-based medical device company focused on developing and manufacturing long-term, implantable balloon therapies for treating stress urinary incontinence (SUI) in both men and women. Their main products are the Adjustable Continence Therapy (ACT®) for women and ProACT™ for men. These therapies involve the minimally invasive implantation of adjustable balloons near the bladder neck, which can be fine-tuned after surgery to improve continence. With over 16,000 successful implants worldwide, Uromedica has established significant clinical experience. ProACT is FDA-approved for sale in the United States, while ACT is currently in clinical trials for female use. The company collaborates with physicians globally to enhance these therapies, aiming to improve patients' quality of life by providing effective solutions for urinary incontinence. Uromedica is dedicated to ongoing product development and maintains strong communication with healthcare providers and patients to support treatment access and education.
Technologies
Keywords
Company Information
-
Employees 33
-
Founded 1997
-
Annual Revenue $4500000
-
Total Funding $1850000
Location
1840 Berkshire Ln N, Plymouth, Minnesota, United States, 55441